ACLS

Business Context and Reporting Period

Axcelis Technologies, Inc. is a leading producer of ion implantation, dry strip, photostabilization, and rapid thermal processing equipment for semiconductor fabrication. The company operates globally and maintains a 50-50 joint venture in Japan, Sumitomo Eaton Nova Corporation (SEN). This Form 10-Q covers the quarterly period ended June 30, 2002, and the six-month period ended on the same date.

Key Financial Metrics

Cash Flow (Six Months Ended June 30, 2002):

• Net cash used by operating activities: $(29.79) million
• Net cash used by investing activities: $(21.44) million
• Net cash provided by financing activities: $124.42 million (primarily from debt proceeds)
• Net increase in cash and cash equivalents: $74.58 million

Material Changes Versus Prior Period

• Revenue Decline: Net sales decreased 12.8% in the quarter and 40.6% year-to-date compared to 2001, driven by reduced capital spending by semiconductor customers.
• Profitability: The company shifted from an operating income of $1.17 million in the first half of 2001 to an operating loss of $34.99 million in the first half of 2002. Gross margins compressed due to lower manufacturing capacity utilization.
• Expense Reductions: Operating expenses decreased in absolute dollars due to headcount reductions and lower amortization of goodwill following the adoption of SFAS No. 142. However, as a percentage of sales, expenses increased significantly due to the revenue drop.
• Joint Venture Income: Equity income from SEN dropped significantly year-to-date ($1.36 million vs. $10.20 million in 2001) due to the downturn in the Japanese semiconductor market.
• Debt Issuance: The company incurred interest expense in 2002 related to a $125 million convertible subordinated note offering completed in January 2002, whereas no such expense existed in the comparable 2001 period.

Guidance, Outlook, Risks, and Unusual Items

Outlook and Liquidity: Management believes available cash and operating cash flows will satisfy working capital and capital expenditure commitments. The company expects to consume cash at the beginning of a cyclical upturn and generate cash at the beginning of a downturn due to working capital dynamics.

Unusual Items and Accounting Changes:

• SFAS No. 142 Adoption: The company adopted new accounting standards in Q1 2002, eliminating the amortization of goodwill. This reduced amortization expenses by approximately $3.9 million year-to-date compared to 2001.
• Deferred Tax Assets: The company holds approximately $50.4 million in deferred tax assets (loss carryforwards) with no valuation allowance recorded. Management estimates these will be fully utilized within three years; however, a valuation allowance may be required if future taxable losses continue.

Risk Factors: Key risks include the cyclical nature of the semiconductor industry, rapid technological changes, intense competition, and dependency on the SEN joint venture for access to the Japanese market.

Investor Verification Checklist

• Deferred Tax Asset Realization: Verify the assumptions regarding future taxable income used to justify the lack of a valuation allowance on the $50.4 million deferred tax asset.
• Revenue Recognition Policy: Confirm that post-delivery acceptance provisions remain "routine" and "commercially inconsequential" to ensure revenue recognition timing does not require revision.
• Joint Venture Performance: Monitor the financial health of Sumitomo Eaton Nova Corporation (SEN), as royalty and equity income are significant components of other income.
• Inventory Valuation: Review inventory allowances ($13.9 million) for adequacy given the significant decline in sales volume and potential for obsolescence.
• Debt Covenants: Review the terms of the $125 million convertible subordinated notes issued in January 2002 for any covenants that could be impacted by continued operating losses.